IL17A and breast carcinoma: Analyzing gene-expression profile of non-metastatic breast cancer cell lines, that were either treated or not treated with IL17A, Benevides and colleagues identified 1,742 upregulated and 2,592 downregulated genes in the IL17-treated cells compared to untreated cells (23).